High-proliferative activity (>50%) is related to an elevated recurrence risk after surgery in patients with stage I tumours, making Ki-67 a potentially useful marker for patients in need of more extensive treatment (ie surgery with more extensive margins, neck dissection and postoperative radiotherapy). This evidence concerns the gene MKI67 and neoplasm.